Summit Therapeutics Inc.
SMMT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001599298
No open-market purchases or sales by Summit Therapeutics Inc. insiders were filed in the last 90 days; 242 institutions reported holding it in 13F filings for Q2 2026, worth $1.98B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Summit Therapeutics Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +1 vs. Q2 2022
- Shares held
- 3.18M
- −5.28M (−62.4%) vs. Q2 2022
- Total value
- $3.78M
- −$4.68M (−55.3%) vs. Q2 2022
- New holders
- 11
- 14 more added
- Sold out
- 10
- 4 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SMMT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 242 | $1.98B |
| Q1 2026 | 222 | $2.25B |
| Q4 2025 | 206 | $2.06B |
| Q3 2025 | 232 | $2.13B |
| Q2 2025 | 226 | $2.08B |
| Q1 2025 | 202 | $1.91B |
| Q4 2024 | 196 | $1.65B |
| Q3 2024 | 164 | $1.85B |
| Q2 2024 | 121 | $563.0M |
| Q1 2024 | 103 | $205.5M |
| Q4 2023 | 95 | $84.4M |
| Q3 2023 | 91 | $60.4M |
| Q2 2023 | 96 | $87.6M |
| Q1 2023 | 86 | $37.0M |
| Q4 2022 | 57 | $34.5M |
| Q3 2022 | 42 | $3.78M |
| Q2 2022 | 41 | $8.46M |
| Q1 2022 | 48 | $27.4M |
| Q4 2021 | 52 | $30.0M |
| Q3 2021 | 51 | $55.3M |
| Q2 2021 | 54 | $82.4M |
| Q1 2021 | 38 | $54.5M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Summit Therapeutics Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 775,922 | $923.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 431,560 | $514.0K | 0.00% | −25,908−5.7% | Reduced |
| BlackRock Inc. | 421,086 | $500.0K | 0.00% | +118,878+39.3% | Added |
| Morgan Stanley | 351,337 | $418.0K | 0.00% | +142,144+67.9% | Added |
| Geode Capital Management, LLC | 324,292 | $385.0K | 0.00% | +269,937+496.6% | Added |
| Marshall Wace, LLP | 140,660 | $167.0K | 0.00% | +140,660 | New |
| Bridgeway Capital Management, LLC | 89,100 | $106.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 81,707 | $97.0K | 0.00% | +58,070+245.7% | Added |
| Goldman Sachs Group Inc | 60,740 | $72.0K | 0.00% | +26,347+76.6% | Added |
| UBS Group AG | 49,245 | $58.0K | 0.00% | −14,091−22.2% | Reduced |
| Mercer Global Advisors Inc | 42,300 | $50.0K | 0.00% | +2,100+5.2% | Added |
| Advisor Group Holdings, Inc. | 40,374 | $48.0K | 0.00% | +29,774+280.9% | Added |
| Levin Capital Strategies, L.P. | 39,176 | $47.0K | 0.01% | 00.0% | Unchanged |
| Hoylecohen, LLC | 30,432 | $36.0K | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 28,500 | $35.0K | 0.00% | +28,500 | New |
| Group One Trading, L.P. | 24,714 | $29.0K | 0.00% | +24,714 | New |
| Northern Trust Corp | 22,903 | $27.0K | 0.00% | +22,903 | New |
| Wells Fargo & Company | 21,100 | $25.0K | 0.00% | +200+1.0% | Added |
| Jane Street Group, LLC | 20,259 | $24.0K | 0.00% | +20,259 | New |
| Cowen and Company, LLC | 17,249 | $21.0K | 0.00% | −800−4.4% | Reduced |
| Qube Research & Technologies Ltd | 17,120 | $20.0K | 0.00% | −1,691−9.0% | Reduced |
| Inscription Capital, LLC | 17,000 | $20.0K | 0.01% | 00.0% | Unchanged |
| ProShare Advisors LLC | 16,925 | $20.0K | 0.00% | +16,925 | New |
| Two Sigma Securities, LLC | 17,092 | $20.0K | 0.00% | +17,092 | New |
| Man Group plc | 15,719 | $19.0K | 0.00% | +15,719 | New |
| Bender Robert & Associates | 14,059 | $17.0K | 0.01% | 00.0% | Unchanged |
| Vance Wealth, Inc. | 13,299 | $16.0K | 0.01% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 12,392 | $15.0K | 0.00% | +7,257+141.3% | Added |
| Tower Research Capital LLC (TRC) | 11,391 | $14.0K | 0.00% | +2,028+21.7% | Added |
| Evoke Wealth, LLC | 8,000 | $10.0K | 0.00% | +3,000+60.0% | Added |
| Osterweis Capital Management Inc | 5,000 | $6.00K | 0.00% | +5,000 | New |
| National Bank of Canada | 3,241 | $4.00K | 0.00% | 00.0% | Unchanged |
| Adirondack Trust Co | 2,500 | $3.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 2,549 | $3.00K | 0.00% | +829+48.2% | Added |
| Barclays PLC | 2,089 | $2.00K | 0.00% | +961+85.2% | Added |
| Bank of America Corp | 1,684 | $2.00K | 0.00% | +1,478+717.5% | Added |
| China Universal Asset Management Co., Ltd. | 1,885 | $2.00K | 0.00% | +1,885 | New |
| BNP Paribas Arbitrage, SA | 1,159 | $1.38K | 0.00% | +1,159 | New |
| Harbour Investments, Inc. | 1,300 | $1.00K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 334 | $0 | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Bradley & Co. Private Wealth Management, LLC | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Polar Capital Holdings Plc | 0 | $0 | 0.00% | −5,599,407−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −100,722−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −81,559−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −56,743−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −49,118−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −10,355−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −217−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −63−100.0% | Sold out |